Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peritubal bupivacaine plus morphine infiltration for pain control after percutaneous nephrolithotomy
ACTRN12617000431325Phase 4Completed
- Sponsor
- Isra Karaduman
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine and morphine in postoperative pain (2 arms), sponsored by Isra Karaduman. Primary endpoints: Analgesic consumption in first 24 hours and Pain at rest and during movement. Started May 2015; status: completed.
02
Drugs
bupivacainemorphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12617000431325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000431325.